₹237.7
▼ -3.79 -1.57%
17 Jul 2026
NSE Listed
Chandan Healthcare Ltd. (CHANDAN)
Volume: 21,600Avg Vol 1W: 24,320Avg Vol 1M: 79,08052W Range:₹185.4₹358
Key Ratios
Checked 6h agoMarket Cap₹591 Cr
Current Price₹237.7
Previous Close₹241.49
High / Low (52w)₹358 / ₹185.4
Volume21,600
Avg Vol (1W)24,320
Avg Vol (1M)79,080
Stock P/E85.34
Book Value₹69.48
Dividend Yield0%
ROE15.82%
ROA9.86%
Revenue (TTM)₹232 Cr
Revenue Growth30.3%
Profit Margin9.79%
Total Debt₹22 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹11.96
P/B3.48
Debt / Equity0.51
50 DMA₹239.48
200 DMA₹272.47
Day change-1.57%
Price Chart
₹237.7▲ 13.84% · 1Y
2025-07-172026-07-16
20-day avg volume: 79K shares
Pros
- Healthy return on equity of 15.8%.
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Revenue fell 24% YoY.
- Stock trades at a high P/E of 85.
Quarterly Results
| Metric | Dec 2024 | Mar 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | ₹55 Cr | ₹63 Cr | ₹68 Cr | ₹65 Cr | ₹76 Cr |
| EBITDA | ₹8 Cr | ₹10 Cr | ₹13 Cr | ₹10 Cr | ₹12 Cr |
| Net Profit | ₹4 Cr | ₹6 Cr | ₹8 Cr | ₹5 Cr | ₹7 Cr |
| EPS | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | ₹67 Cr | ₹87 Cr | ₹120 Cr | ₹137 Cr | ₹178 Cr | ₹232 Cr |
| EBITDA | ₹4 Cr | ₹4 Cr | ₹1 Cr | ₹7 Cr | ₹24 Cr | ₹37 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹-1 Cr | ₹3 Cr | ₹16 Cr | ₹22 Cr |
| EPS | 1.17 | 0.44 | -0.55 | 1.68 | 8.14 | 10.78 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹59 Cr | ₹65 Cr | ₹82 Cr | ₹98 Cr | ₹118 Cr | ₹211 Cr |
| Total Liabilities | ₹35 Cr | ₹41 Cr | ₹55 Cr | ₹68 Cr | ₹74 Cr | ₹84 Cr |
| Equity | ₹24 Cr | ₹24 Cr | ₹26 Cr | ₹30 Cr | ₹44 Cr | ₹126 Cr |
| Total Debt | ₹7 Cr | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹-6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹-21 Cr |
| Investing | ₹7 Cr | ₹-11 Cr | ₹-6 Cr | ₹-15 Cr | ₹-36 Cr |
| Financing | ₹-1 Cr | ₹3 Cr | ₹2 Cr | ₹16 Cr | ₹67 Cr |
| Free Cash Flow | ₹-6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹-20 Cr |
Shareholding
Promoter 49.55% Institutions 5.04% Public 45.42%
Efficiency & Working Capital
ROCE19.6%
Interest Coverage8
Dividend Payout—
Debtor Days74 d
Inventory Days50 d
Payable Days41 d
Cash Conversion Cycle83 d
Working Capital Days124 d
Shareholding Details
As of 2026-03-31
Promoter49.5%
FII0%
DII5%
Institutions5%
Public45.4%
Promoter Pledge0%
No. of Shareholders1,624
Shareholding Pattern
Quarterly — figures in %. Latest 6 quarters.
| Period | Sept 2024 | Feb 2025 | Mar 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 69.9% | 49.2% | 49.4% | 49.5% | 49.5% | 49.5% |
| FIIs | 0% | 6.5% | 3.9% | 1.1% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 4.8% | 5% |
| Public | 30.1% | 44.3% | 46.7% | 49.4% | 45.8% | 45.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 59 | 3,099 | 897 | 1,307 | 1,464 | 1,624 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Amaranita Holdings (india) Private Limited | Shareholding of Promoter and Promoter Group | 16.9% | 41,28,064 |
| Amar Singh | Shareholding of Promoter and Promoter Group | 9.6% | 23,46,260 |
| Vinay Lamba | Shareholding of Promoter and Promoter Group | 6.5% | 15,84,800 |
| Vijay Singh | Shareholding of Promoter and Promoter Group | 3.7% | 8,99,400 |
| Shaleen Solanki | Shareholding of Promoter and Promoter Group | 3.7% | 9,00,000 |
| Negen Undiscovered Value Fund | Public Shareholding | 3.2% | 7,73,600 |
| Vikas Lamba | Shareholding of Promoter and Promoter Group | 1.8% | 4,50,000 |
| Shweta Lamba | Public Shareholding | 1.7% | 4,19,400 |
| Anant Wealth Consultants | Public Shareholding | 1.6% | 3,97,600 |
| Hari Shanker Dixit | Public Shareholding | 1.4% | 3,50,000 |
| Shalu Aggarwal | Public Shareholding | 1.4% | 3,48,000 |
| Amit Srivastava | Public Shareholding | 1.4% | 3,42,240 |
| Amita Singh | Public Shareholding | 1.4% | 3,40,000 |
| Bimla Singh | Shareholding of Promoter and Promoter Group | 1.3% | 3,25,980 |
| Sandeep Kumar Saraswat | Public Shareholding | 1.3% | 3,15,200 |
| Vivek Dixit | Public Shareholding | 1.2% | 3,00,000 |
| Alok Singh | Shareholding of Promoter and Promoter Group | 1.2% | 3,00,000 |
| Rajeev Lochan | Public Shareholding | 1.2% | 2,90,400 |
| Vikalp Dixit | Public Shareholding | 1.1% | 2,78,200 |
| Keya Vimal Salot | Public Shareholding | 1.1% | 2,73,600 |
| Dharmendra Singh Malik | Shareholding of Promoter and Promoter Group | 1% | 2,41,500 |
| Nisha Lamba | Shareholding of Promoter and Promoter Group | 0.9% | 2,23,300 |
| Asmita Singh | Shareholding of Promoter and Promoter Group | 0.7% | 1,67,600 |
| Vishal Lamba | Shareholding of Promoter and Promoter Group | 0.6% | 1,53,580 |
| Anant Singh | Shareholding of Promoter and Promoter Group | 0.5% | 1,13,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Nisha Lamba | 0 | 0% | 2026-03-31 |
| Vinay Lamba | 0 | 0% | 2026-03-31 |
| Vishal Lamba | 0 | 0% | 2026-03-31 |
| Vikas Lamba | 0 | 0% | 2026-03-31 |
| Amar Singh | 0 | 0% | 2026-03-31 |
| Ajai Singh | 0 | 0% | 2026-03-31 |
| Shital Singh Solanki | 0 | 0% | 2026-03-31 |
| Vijay Singh | 0 | 0% | 2026-03-31 |
| Dharmendra Singh Malik | 0 | 0% | 2026-03-31 |
| Bimla Singh | 0 | 0% | 2026-03-31 |
| Shaleen Solanki | 0 | 0% | 2026-03-31 |
| Anant Singh | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| AMAR SINGH | Chairman & Managing Director | 2025 |
| Vinay Lamba | Non Executive Director | 2025 |
| ASMITA SINGH | Managing Director | 2025 |
| Amit Gupta | Independent Non Exe. Director | 2025 |
| Vinod Jain | Independent Director | 2025 |
| Brahma Nand Bhartiya | Independent Non Exe. Director | 2025 |
| HARI SHANKER DIXIT | Non Executive Director | 2025 |
| Rajeev Nain | CFO / Company Secretary / Compliance Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| State-of-the-art laboratories provi | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 24 | 24 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | -0 | 9 | 7 |
| 2024 | 0 | 0 | 0 | 0 | 13 | 13 |
| 2024 | 0 | 0 | 0 | 1 | 1 | 2 |
Company Information
🌐 www.chandandiagnostic.com ↗
📍 Biotech Park Sector G, Jankipuram Kursi Road, Lucknow, Uttar Pradesh, 226021
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search